论文信息 - Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial - 字舞流文

Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial

O. McCarty | A. Gruber | M. Hinds | Matthew W. Hagen | D. Gailani | C. Puy | E. Tucker | J. Shatzel | N. G. Verbout | S. Olson | M. Wallisch | C. Lorentz | Norah G. Verbout